Shares of Phibro Animal Health Co. (NASDAQ:PAHC – Get Free Report) hit a new 52-week high during trading on Tuesday . The stock traded as high as $22.55 and last traded at $22.41, with a volume of 28341 shares changing hands. The stock had previously closed at $21.53.
Analysts Set New Price Targets
Several research analysts have issued reports on the stock. Bank of America raised their price target on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. began coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 target price on the stock. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $15.00.
Check Out Our Latest Analysis on Phibro Animal Health
Phibro Animal Health Stock Performance
Phibro Animal Health Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a dividend of $0.12 per share. The ex-dividend date is Wednesday, September 4th. This represents a $0.48 annualized dividend and a yield of 2.14%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 150.00%.
Insider Activity at Phibro Animal Health
In other news, Director E Thomas Corcoran bought 5,000 shares of the stock in a transaction dated Wednesday, September 4th. The stock was bought at an average price of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the acquisition, the director now directly owns 25,000 shares in the company, valued at approximately $500,500. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 50.06% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Phibro Animal Health
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. CWM LLC grew its holdings in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after acquiring an additional 1,035 shares in the last quarter. Fidelis Capital Partners LLC purchased a new position in Phibro Animal Health in the first quarter worth $46,000. China Universal Asset Management Co. Ltd. grew its stake in Phibro Animal Health by 65.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock valued at $50,000 after purchasing an additional 1,531 shares during the period. Quest Partners LLC purchased a new stake in shares of Phibro Animal Health during the 4th quarter valued at $56,000. Finally, Summit Securities Group LLC bought a new stake in shares of Phibro Animal Health during the 2nd quarter worth $83,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.
About Phibro Animal Health
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Articles
- Five stocks we like better than Phibro Animal Health
- What is a Dividend King?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- 3 Fintech Stocks With Good 2021 Prospects
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.